Chong Kun Dang Pharmaceutical (185750) - Total Liabilities

Latest as of March 2026: ₩803.02 Billion KRW ≈ $544.20 Million USD

Based on the latest financial reports, Chong Kun Dang Pharmaceutical (185750) has total liabilities worth ₩803.02 Billion KRW (≈ $544.20 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Chong Kun Dang Pharmaceutical (185750) net asset momentum to track the company's year-over-year net asset growth rate.

Chong Kun Dang Pharmaceutical - Total Liabilities Trend (2016–2025)

This chart illustrates how Chong Kun Dang Pharmaceutical's total liabilities have evolved over time, based on quarterly financial data. See Chong Kun Dang Pharmaceutical free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Chong Kun Dang Pharmaceutical Competitors by Total Liabilities

The table below lists competitors of Chong Kun Dang Pharmaceutical ranked by their total liabilities.

Company	Country	Total Liabilities
Ray Sigorta AS IS:RAYSG	Turkey	TL32.93 Billion
Royce Micro Cap Closed Fund NYSE:RMT	USA	$20.93 Million
Jiangsu Liba Enterprise Joint-Stock Co Ltd SHG:603519	China	CN¥373.84 Million
Ji'an Mankun Technology Co. Ltd. A SHE:301132	China	CN¥1.16 Billion
SK Discovery Co Ltd KO:006120	Korea	₩10.75 Trillion
EPC Groupe PA:EXPL	France	€314.97 Million
Shenzhen Guangju Energy Co Ltd SHE:000096	China	CN¥546.23 Million
Bestlink Tech Co Ltd SHG:603206	China	CN¥5.51 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Chong Kun Dang Pharmaceutical's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Chong Kun Dang Pharmaceutical (185750) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.00	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.78	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.44	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Chong Kun Dang Pharmaceutical's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Chong Kun Dang Pharmaceutical (2016–2025)

The table below shows the annual total liabilities of Chong Kun Dang Pharmaceutical from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩793.94 Billion ≈ $538.04 Million	+41.17%
2024-12-31	₩562.39 Billion ≈ $381.12 Million	-4.16%
2023-12-31	₩586.79 Billion ≈ $397.66 Million	+16.52%
2022-12-31	₩503.59 Billion ≈ $341.28 Million	+4.72%
2021-12-31	₩480.89 Billion ≈ $325.89 Million	+21.82%
2020-12-31	₩394.74 Billion ≈ $267.51 Million	+20.94%
2019-12-31	₩326.40 Billion ≈ $221.20 Million	+16.32%
2018-12-31	₩280.60 Billion ≈ $190.16 Million	+2.44%
2017-12-31	₩273.91 Billion ≈ $185.63 Million	-4.71%
2016-12-31	₩287.45 Billion ≈ $194.80 Million	--

About Chong Kun Dang Pharmaceutical

KO:185750 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$597.37 Million

₩881.48 Billion KRW

Market Cap Rank

#11150 Global

#286 in Korea

Share Price

₩66900.00

Change (1 day)

-0.45%

52-Week Range

₩64100.00 - ₩97700.00

All Time High

₩207617.05